The monoclonal-antibody combination AZD7442 is composed of tixagevimab and cilgavimab, two neutralizing antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that have an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback